Cargando…

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing

Chimeric antigen receptor T cell (CAR-T cell) therapy is a relatively new, effective, and rapidly evolving therapeutic for adoptive immunotherapies. Although it has achieved remarkable effect in hematological malignancies, there are some problems that remain to be resolved. For example, there are hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Meng, Jin, Xin, Sun, Rui, Xiong, Xia, Wang, Jiaxi, Xie, Danni, Zhao, MingFeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650271/ https://www.ncbi.nlm.nih.gov/pubmed/34876185 http://dx.doi.org/10.1186/s12967-021-03165-x

Ejemplares similares

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
por: Jin, Xin, et al.
Publicado: (2022)

Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies
por: Xie, Danni, et al.
Publicado: (2022)

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
por: Jin, Xin, et al.
Publicado: (2023)

Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia
por: Xu, XiaoQiang, et al.
Publicado: (2023)

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape
por: Xie, Danni, et al.
Publicado: (2023)

Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
por: Tyagarajan, Seshu, et al.
Publicado: (2019)

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
por: Pellegrino, Marsha, et al.
Publicado: (2020)

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies
por: Zhang, Meng, et al.
Publicado: (2022)

Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor Efficacy
por: Xia, Wenjiao, et al.
Publicado: (2023)

Global Manufacturing of CAR T Cell Therapy
por: Levine, Bruce L., et al.
Publicado: (2016)

Determination of CAR T cell metabolism in an optimized protocol
por: Joaquina, Sandy, et al.
Publicado: (2023)

Impact of Manufacturing Procedures on CAR T Cell Functionality
por: Watanabe, Norihiro, et al.
Publicado: (2022)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy
por: Wang, Jiaxi, et al.
Publicado: (2023)

Role of CAR T Cell Metabolism for Therapeutic Efficacy
por: Rial Saborido, Judit, et al.
Publicado: (2022)

Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions
por: Dong, Zhenyuan, et al.
Publicado: (2020)

Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1
por: Zhang, Rui, et al.
Publicado: (2023)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Revolutionizing car body manufacturing using a unified steel metallurgy concept
por: Lu, Qi, et al.
Publicado: (2021)

The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
por: Zhang, Meng, et al.
Publicado: (2022)

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma
por: Zhang, Huanxin, et al.
Publicado: (2022)

Hot stamping advanced manufacturing technology of lightweight car body
por: Hu, Ping, et al.
Publicado: (2017)

Clinical manufacturing of CAR T cells: foundation of a promising therapy
por: Wang, Xiuyan, et al.
Publicado: (2016)

Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
por: Dukes, Meghan W., et al.
Publicado: (2023)

Characterization of Complex Concentrated Alloys and Their Potential in Car Brake Manufacturing
por: Anasiei, Ioana, et al.
Publicado: (2023)

Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
por: Yang, Quanjun, et al.
Publicado: (2022)

Overhauling CAR T Cells to Improve Efficacy, Safety and Cost
por: Chicaybam, Leonardo, et al.
Publicado: (2020)

Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
por: Kyte, Jon Amund
Publicado: (2022)

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease
por: Lu, Wenyi, et al.
Publicado: (2021)

Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL
por: He, Xiaoyuan, et al.
Publicado: (2019)

Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
por: Cao, Xinping, et al.
Publicado: (2023)

Large-scale manufacturing and characterization of CMV-CD19CAR T cells
por: Wang, Xiuli, et al.
Publicado: (2022)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

Structure optimization and mechanical study on lifting mechanism of the multifunctional car transporter
por: Nie, Qian-Yue, et al.
Publicado: (2022)

Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
por: Balke-Want, Hyatt, et al.
Publicado: (2023)

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
por: Jackson, Zachary, et al.
Publicado: (2020)

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
por: Liu, Yifan, et al.
Publicado: (2023)

Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
por: Li, Wenshuai, et al.
Publicado: (2023)

Infection Temperature Affects the Phenotype and Function of Chimeric Antigen Receptor T Cells Produced via Lentiviral Technology
por: Jin, Xin, et al.
Publicado: (2021)

IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
por: Du, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a2sd80hcrnuv85rt4gnu7l4n2p